Skip to content

Clinical trials

Phase 2 Glioblastoma trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glioblastoma Phase: Phase 2 Country / region: United Kingdom Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20091
20114
20121
20132
20151
20172
20191
20211
20222
20231
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Recruiting4
Terminated4
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC5
University College, London4
Hoffmann-La Roche2
AbbVie1
Apollomics Inc.1
Bayer1
CRISM Therapeutics LTD1
Cambridge University Hospitals NHS Foundation Trust1
Incyte Corporation1
Merck Sharp & Dohme LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glioblastoma22
Brain Neoplasms10
Astrocytoma6
Central Nervous System Neoplasms6
Glioma6
Gliosarcoma6
Oligodendroglioma5
Pancreatic Neoplasms3
Diffuse Intrinsic Pontine Glioma2
Ovarian Neoplasms2

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.